International Journal of Cardiology
Volume 149, Issue 3 , Pages 341-346 , 16 June 2011

Epicardial application of an amiodarone-releasing hydrogel to suppress atrial tachyarrhythmias

  • Robert W. Bolderman

      Affiliations

    • Cardiovascular Research Institute Maastricht, Department of Cardiothoracic Surgery, Maastricht, The Netherlands
    • Corresponding Author InformationCorresponding author. Cardiovascular Research Institute Maastricht, Department of Cardiothoracic Surgery, Universiteitssingel 50, P.O. Box 616, 6200 MD Maastricht, The Netherlands. Tel.: +31 43 3881066; fax: +31 43 3877075.
    • ,
  • J.J. Rob Hermans

      Affiliations

    • Cardiovascular Research Institute Maastricht, Department of Pharmacology, Maastricht, The Netherlands
    • ,
  • Leonard M. Rademakers

      Affiliations

    • Cardiovascular Research Institute Maastricht, Department of Cardiothoracic Surgery, Maastricht, The Netherlands
    • ,
  • Monique M.J. de Jong

      Affiliations

    • Cardiovascular Research Institute Maastricht, Department of Cardiothoracic Surgery, Maastricht, The Netherlands
    • ,
  • Peter Bruin

      Affiliations

    • DSM Biomedical, Geleen, The Netherlands
    • ,
  • Aylvin A. Dias

      Affiliations

    • DSM Biomedical, Geleen, The Netherlands
    • ,
  • Frederik H. van der Veen

      Affiliations

    • Cardiovascular Research Institute Maastricht, Department of Cardiothoracic Surgery, Maastricht, The Netherlands
    • ,
  • Jos G. Maessen

      Affiliations

    • Cardiovascular Research Institute Maastricht, Department of Cardiothoracic Surgery, Maastricht, The Netherlands

Received 1 November 2009 ,Revised 18 December 2009 ,Accepted 6 February 2010.

References 

  1. Zimetbaum P. Amiodarone for atrial fibrillation. N Engl J Med. 2007;356:935–941
  2. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Bergmann JF. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev. 2007;CD005049
  3. Singh BN. Amiodarone as paradigm for developing new drugs for atrial fibrillation. J Cardiovasc Pharmacol. 2008;52:300–305
  4. Kodama I, Kamiya K, Toyama J. Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent. Am J Cardiol. 1999;84:20R–28R
  5. Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA. 2007;298:1312–1322
  6. Camm AJ. Safety considerations in the pharmacological management of atrial fibrillation. Int J Cardiol. 2008;127:299–306
  7. Ayers GM, Rho TH, Ben-David J, Besch HR, Zipes DP. Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation. J Cardiovasc Electrophysiol. 1996;7:713–721
  8. Darsinos JT, Karli JN, Samouilidou EC, Krumbholz B, Pistevos AC, Levis GM. Distribution of amiodarone in heart tissues following intrapericardial administration. Int J Clin Pharmacol Ther. 1999;37:301–306
  9. Bolderman RW, Hermans JJ, Rademakers LM, et al. Intrapericardial delivery of amiodarone and sotalol: atrial transmural drug distribution and electrophysiological effects. J Cardiovasc Pharmacol. 2009;54:355–363
  10. Kolettis TM, Kazakos N, Katsouras CS, et al. Intrapericardial drug delivery: pharmacologic properties and long-term safety in swine. Int J Cardiol. 2005;99:415–421
  11. Bartoli CR, Akiyama I, Godleski JJ, Verrier RL. Long-term pericardial catheterization is associated with minimum foreign-body response. Catheter Cardiovasc Interv. 2007;70:221–227
  12. Labhasetwar V, Underwood T, Gallagher M, Murphy G, Langberg J, Levy RJ. Sotalol controlled-release systems for arrhythmias: in vitro characterization, in vivo drug disposition, and electrophysiologic effects. J Pharm Sci. 1994;83:156–164
  13. Zhang G, Nakamura Y, Wang X, Hu Q, Suggs LJ, Zhang J. Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+cell homing to the infarcted heart. Tissue Eng. 2007;13:2063–2071
  14. Hendrikx M, Mees U, Hill AC, Egbert B, Coker GT, Estridge TD. Evaluation of a novel synthetic sealant for inhibition of cardiac adhesions and clinical experience in cardiac surgery procedures. Heart Surg Forum. 2001;4:204–210
  15. Konertz WF, Kostelka M, Mohr FW, et al. Reducing the incidence and severity of pericardial adhesions with a sprayable polymeric matrix. Ann Thorac Surg. 2003;76:1270–1274
  16. Wallace DG, Cruise GM, Rhee WM, et al. A tissue sealant based on reactive multifunctional polyethylene glycol. J Biomed Mater Res. 2001;58:545–555
  17. Bolderman RW, Hermans JJ, Maessen JG. Determination of the class III antiarrhythmic drugs dronedarone and amiodarone, and their principal metabolites in plasma and myocardium by high-performance liquid chromatography and UV-detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:1727–1731
  18. Holt DW, Tucker GT, Jackson PR, Storey GC. Amiodarone pharmacokinetics. Am Heart J. 1983;106:840–847
  19. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291:1720–1729
  20. Sintov A, Scott W, Dick M, Levy RJ. Cardiac controlled release for arrhythmia therapy: lidocaine-polyurethane matrix studies. J Control Release. 1988;8:157–165
  21. Siden R, Flowers WE, Levy RJ. Epicardial propranolol administration for ventricular arrhythmias in dogs: matrix formulation and characterization. Biomaterials. 1992;13:764–770
  22. Siden R, Kadish A, Flowers W, et al. Epicardial controlled-release verapamil prevents ventricular tachycardia episodes induced by acute ischemia in a canine model. J Cardiovasc Pharmacol. 1992;19:798–809
  23. Labhasetwar V, Underwood T, Heil RW, Gallagher M, Langberg J, Levy RJ. Epicardial administration of ibutilide from polyurethane matrices: effects on defibrillation threshold and electrophysiologic parameters. J Cardiovasc Pharmacol. 1994;24:826–840
  24. Burashnikov A, Di Diego JM, Sicouri S, Ferreiro M, Carlsson L, Antzelevitch C. Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation. Heart Rhythm. 2008;5:1735–1742
  25. Verrier RL, Waxman S, Lovett EG, Moreno R. Transatrial access to the normal pericardial space: a novel approach for diagnostic sampling, pericardiocentesis, and therapeutic interventions. Circulation. 1998;98:2331–2333
  26. Maisch B, Ristic AD, Rupp H, Spodick DH. Pericardial access using the PerDUCER and flexible percutaneous pericardioscopy. Am J Cardiol. 2001;88:1323–1326
  27. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–666
  28. Kikuchi K, McDonald AD, Sasano T, Donahue JK. Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer. Circulation. 2005;111:264–270
  29. Mei L, Jin X, Song C, Wang M, Levy RJ. Immobilization of gene vectors on polyurethane surfaces using a monoclonal antibody for localized gene delivery. J Gene Med. 2006;8:690–698
  30. Kutschka I, Chen IY, Kofidis T, et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation. 2006;114:I167–I173
  31. Lin CC, Anseth KS. PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm Res. 2009;26:631–643
  32. Page PL, Plumb VJ, Okumura K, Waldo AL. A new animal model of atrial flutter. J Am Coll Cardiol. 1986;8:872–879
  33. Kumagai K, Khrestian C, Waldo AL. Simultaneous multisite mapping studies during induced atrial fibrillation in the sterile pericarditis model. Insights into the mechanism of its maintenance. Circulation. 1997;95:511–521
  34. Vereckei A, Gorski JC, Ujhelyi M, Mehra R, Zipes DP. Intrapericardial ibutilide administration fails to terminate pacing-induced sustained atrial fibrillation in dogs. Cardiovasc Drugs Ther. 2004;18:269–277
  35. Van Brakel TJ, Hermans JJ, Accord RE, et al. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20:207–215
  36. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

PII: S0167-5273(10)00080-X

doi: 10.1016/j.ijcard.2010.02.014

International Journal of Cardiology
Volume 149, Issue 3 , Pages 341-346 , 16 June 2011

Article Tools

* Image Usage & Resolution